Top-News

Xenetic Biosciences, Inc. News

Keine aktuellen Kursdaten verfügbar
ISIN: US9840152063
Typ: Aktie

Xenetic Biosciences, Inc. News

27.04.22 - ACCESSWIRE
Xenetic Biosciences, Inc. Expands Oncology Pipeline with In-Licensing of DNase Based Oncology Platform Comprising Multiple Therapeutic Modalities
Transaction with CLS Therapeutics for DNase platform includes two pre-​clinical development programs and creates near-term clinical development opportunity
23.03.22 - ACCESSWIRE
Xenetic Biosciences, Inc. Reports Full Year 2021 Financial Results and Provides Business Update
- XCART TM continuing to advance toward IND-​enabling studies
20.07.21 - PR Newswire
Thinking about buying stock in Neurobo Pharmaceuticals, Xenetic Biosciences, Amneal Pharmaceuticals, PLx Pharma, or Orbital Energy Group?
Thinking about buying stock in Neurobo Pharmaceuticals, Xenetic Biosciences, Amneal Pharmaceuticals, PLx Pharma, or Orbital Energy Group? PR Newswire
09.12.20 - PR Newswire
Thinking about buying stock in Xenetic Biosciences, Sundial Growers, Norwegian Cruise Line, Delta Air Lines, or Callon Petroleum?
Thinking about buying stock in Xenetic Biosciences, Sundial Growers, Norwegian Cruise Line, Delta Air Lines, or Callon Petroleum? PR Newswire
15.06.20 - PR Newswire
Thinking about buying stock in Fluidigm Corp, Xenetic Biosciences, Delta Air Lines, Occidental Petroleum Corp, or FuelCell Energy?
Thinking about buying stock in Fluidigm Corp, Xenetic Biosciences, Delta Air Lines, Occidental Petroleum Corp, or FuelCell Energy? PR Newswire
24.06.19 - ACCESSWIRE
Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock
FRAMINGHAM, MA / ACCESSWIRE / June 24, 2019 / Xenetic Biosciences, Inc. (NASDAQ: XBIO) ("Xenetic" or the "Company"), today announced it will effect a one-​for-twelve reverse ...
05.03.19 - ACCESSWIRE
Xenetic Biosciences Announces Pricing of $3.1 Million Registered Direct Offering
FRAMINGHAM, MA / ACCESSWIRE / March 5, 2019 / Xenetic Biosciences, Inc. (NASDAQ: XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on the ...
04.03.19 - ACCESSWIRE
Xenetic Biosciences, Inc. (NASDAQ: XBIO) Announces Agreement to Acquire Innovative CAR T Technology Platform
Innovative XCART platform with demonstrated proof of mechanism and preclinical evidence of target specificity positions Xenetic to address high value oncology market with ...

Newssuche

Videos

newspaper
09:30 Uhr
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »